Pfizer Inc (NYS: PFE) Report Date 2020 2019 2018 2017 Cash & cash equivalents 1,784,000 1,305,000 1,139,000 1,342,000 Short-term investments 10,437,000 8,525,000 17,694,000 18,650,000 Trade accounts receivable 7,930,000 8,724,000 8,025,000 8,221,000 Inventories 8,047,000 8,284,000 7,508,000 7,577,000 Current tax assets 3,264,000 3,344,000 3,374,000 3,050,000 Other current assets 3,438,000 2,600,000 2,461,000 2,289,000 Assets held for sale 167,000 21,000 9,725,000 12,000 Total current assets 35,067,000 32,803,000 49,926,000 41,141,000 Equity-method investments 16,856,000 17,133,000 - - Long-term investments 3,406,000 3,014,000 2,767,000 7,015,000 Property, plant & equipment 13,900,000 13,967,000 13,385,000 13,865,000 Identifiable intangible assets 28,471,000 35,370,000 35,210,000 48,742,000 Goodwill 49,577,000 58,653,000 53,411,000 55,952,000 Noncurrent deferred tax assets & other noncurrent tax assets 2,383,000 2,099,000 1,924,000 1,855,000 Other noncurrent assets 4,569,000 4,450,000 2,799,000 3,227,000 Total assets 154,229,000 167,489,000 159,422,000 171,797,000 Liabilities Short-term borrowings, including current portion of long-term debt 2,703,000 16,195,000 8,831,000 9,953,000 Trade accounts payable 4,309,000 4,220,000 4,674,000 4,656,000 Dividends payable 2,162,000 2,104,000 2,047,000 2,029,000 Income taxes payable 1,049,000 980,000 1,265,000 477,000 Accrued compensation & related items 3,057,000 2,722,000 2,398,000 2,197,000 Other current liabilities 12,640,000 11,083,000 12,643,000 11,115,000 Total current liabilities 25,920,000 37,304,000 31,858,000 30,427,000 Long-term debt 37,133,000 35,955,000 32,909,000 33,538,000 Pension benefit obligations 4,766,000 5,638,000 5,272,000 5,926,000 Postretirement benefit obligations 645,000 1,124,000 1,338,000 1,504,000 Noncurrent deferred tax liabilities 4,063,000 5,578,000 3,700,000 3,900,000 Other taxes payable 11,560,000 12,126,000 14,737,000 18,697,000 Other noncurrent liabilities 6,669,000 6,317,000 5,850,000 6,149,000 Total liabilities 90,756,000 104,042,000 95,664,000 100,141,000 Stockholders' Equity Preferred stock - 17,000 19,000 21,000 Common stock 470,000 468,000 467,000 464,000 Additional paid-in capital 88,674,000 87,428,000 86,253,000 84,278,000 Treasury stock 110,988,000 110,801,000 101,610,000 89,425,000 Retained earnings (accumulated deficit) 96,770,000 97,670,000 89,554,000 85,291,000 Accumulated other comprehensive income (loss) (11,688,000) (11,640,000) (11,275,000) (9,321,000) Equity attributable to noncontrolling interests 235,000 305,000 350,000 348,000 Total equity (deficit) 63,473,000 63,447,000 63,758,000 71,656,000 Pfizer Inc (NYS: PFE) Report Date 2020 2019 2018 Revenues 41,908,000 51,750,000 53,647,000 Cost of sales 8,692,000 10,219,000 11,248,000 Gross Profit 33,216,000 41,531,000 42,399,000 Selling, informational & administrative expenses 11,615,000 14,350,000 14,455,000 Research & development expenses 9,405,000 8,650,000 8,006,000 Amortization of intangible assets 3,436,000 4,610,000 4,893,000 Restructuring charges & certain acquisition-related costs 600,000 747,000 1,044,000 Gain (loss) on completion of Consumer Healthcare JV transaction 6,000 8,086,000 - Interest income 73,000 226,000 333,000 Interest expense 1,449,000 1,574,000 1,316,000 Royalty-related income 770,000 648,000 495,000 other expenses 63,000 2,878,000 1,628,000 Income (loss) from continuing operations before provision for taxes on income 7,497,000 17,682,000 11,885,000 Provision (benefit) for taxes on income 476,000 1,384,000 706,000 Income (loss) from continuing operations after provision for taxes on income 7,021,000 16,298,000 11,179,000 Income (loss) from discontinued operations - net of tax 2,631,000 4,000 9,000 Net income before allocation to noncontrolling interests 9,652,000 16,302,000 11,188,000 Less: net income attributable to noncontrolling interests (36,000) (29,000) (35,000) Net income attributable to Pfizer Inc. 9,616,000 16,273,000 11,153,000 USE THIS INFORMATION ONLY IF NEEDED 2020 2019 2018 2017 Accounts receivable, gross 8,438,000 9,251,000 8,566,000 8,805,000 Less allowance for doubtful accounts 508,000 527,000 541,000 584,000 Land 444,000 516,000 500,000 540,000 Buildings 9,022,000 10,068,000 9,920,000 10,254,000 Machinery & equipment 11,153,000 12,281,000 11,871,000 11,902,000 Furniture, fixtures & other property, plant & equipment4,541,000 4,930,000 4,693,000 4,661,000 Construction in progress 3,552,000 2,960,000 2,992,000 2,680,000 Property, plant & equipment, at cost 28,712,000 30,755,000 29,976,000 30,037,000 Less: accumulated depreciation 14,812,000 - 16,788,000 - 16,591,000 - 16,172,000 - Tax rate 35% 35% 35% 35% Cash from operations 14,403,000 12,588,000 15,827,000 16,470,000 Prepare ratio analyses (for 2020, 2019, and 2018) for both companies. You should include the following ratios in your computations: Profitability ratios o Gross Profit margin o Profit margin o Return on assets o Return on equity Productivity o Inventory Turnover o Accounts Receivable Turnover o PPE Turnover o Asset Turnover Solvency o Debt-to-equity o Times interest earned o Return on Financial leverage Liquidity o Current Ratio o Quick Ratio o Operating cash flow to current liabilities o Working capital